In a report released yesterday, Elyse Greenspan from Wells Fargo maintained a Buy rating on Metlife (MET – Research Report), with a price target of $83.00. The company’s shares closed yesterday at $65.81.
Greenspan covers the Financial sector, focusing on stocks such as Metlife, Allstate, and Arthur J Gallagher & Co. According to TipRanks, Greenspan has an average return of 10.6% and a 64.46% success rate on recommended stocks.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Metlife with a $80.55 average price target, a 22.40% upside from current levels. In a report released yesterday, UBS also maintained a Buy rating on the stock with a $82.00 price target.
See today’s best-performing stocks on TipRanks >>
MET market cap is currently $48.82B and has a P/E ratio of 36.35.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Metlife (MET) Company Description:
Headquartered in New York, MetLife, Inc. is among the largest global providers of insurance and financial services to individual and institutional customers. It offers life insurance, annuities, employee benefits and asset management services. The company operates through the following segments: U.S., Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings.
Read More on MET:
